"Pleural Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
| Descriptor ID |
D010997
|
| MeSH Number(s) |
C04.588.894.797.640 C08.528.694 C08.785.640
|
| Concept/Terms |
Pleural Neoplasms- Pleural Neoplasms
- Neoplasms, Pleural
- Neoplasm, Pleural
- Pleural Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Pleural Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pleural Neoplasms".
This graph shows the total number of publications written about "Pleural Neoplasms" by people in this website by year, and whether "Pleural Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 3 | 0 | 3 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 0 | 4 |
| 2005 | 4 | 1 | 5 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 7 | 0 | 7 |
| 2009 | 3 | 0 | 3 |
| 2010 | 5 | 1 | 6 |
| 2011 | 6 | 0 | 6 |
| 2012 | 10 | 0 | 10 |
| 2013 | 5 | 1 | 6 |
| 2014 | 4 | 0 | 4 |
| 2015 | 7 | 0 | 7 |
| 2016 | 12 | 0 | 12 |
| 2017 | 1 | 0 | 1 |
| 2018 | 11 | 0 | 11 |
| 2019 | 9 | 2 | 11 |
| 2020 | 2 | 0 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 10 | 2 | 12 |
| 2025 | 2 | 0 | 2 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pleural Neoplasms" by people in Profiles.
-
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 Aug; 24(8).
-
Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study. Lancet Oncol. 2026 Jul; 27(7):879-892.
-
The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma. Ann Thorac Surg. 2026 07; 122(1):3-21.
-
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database. J Thorac Oncol. 2026 Jul; 21(7):103681.
-
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations. J Thorac Oncol. 2025 11; 20(11):1615-1625.
-
Treatment of Pleural Mesothelioma: ASCO Guideline Update. J Clin Oncol. 2025 03 10; 43(8):1006-1038.
-
Convolutional Neural Networks for Segmentation of Pleural Mesothelioma: Analysis of Probability Map Thresholds (CALGB 30901, Alliance). J Imaging Inform Med. 2025 Apr; 38(2):967-978.
-
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2024 09 01; 10(9):1179-1186.
-
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024 11; 19(11):1564-1577.
-
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma. Lung Cancer. 2024 09; 195:107928.